15th Jun 2018 15:14
PRESS RELEASE
FOR IMMEDIATE RELEASE
Change of Registered Address
London, UK - 15 June 2018: Ergomed plc (LSE: ERGO) ('Ergomed' or 'the Company'), a company focused on providing specialised services to the pharmaceutical industry, announces that it has changed its registered office address with immediate effect to:
1 Occam Court
Surrey Research Park
Guildford
Surrey GU2 7HJ
United Kingdom
All other details remain the same including the Company's telephone/fax numbers and website (www.ergomedplc.com), which includes the information required by AIM Rule 26.
ENDS
Enquiries:
Ergomed plc | Tel: +44 (0) 1483 503 205 | |
Stephen Stamp (Chief Executive Officer) | ||
Numis Securities Limited | Tel: +44 (0) 20 7260 1000 | |
Michael Meade / Freddie Barnfield (Nominated Adviser) | ||
James Black (Joint Broker) | ||
N+1 Singer | Tel: +44 (0) 20 7496 3000 | |
Aubrey Powel (Joint Broker) | ||
Consilium Strategic Communications - for UK enquiries | Tel: +44 (0) 20 3709 5700 | |
Chris Gardner / Mary-Jane Elliott Ivar Milligan / Philippa Gardner | ||
MC Services - for Continental European enquiries | Tel: +49 211 5292 5222 | |
Anne Hennecke | ||
About Ergomed plc
Ergomed provides specialist services to the pharmaceutical industry spanning all phases of clinical development, post-approval pharmacovigilance and medical information. Ergomed's fast-growing, profitable services offering encompasses a complete suite of specialist pharmacovigilance solutions, integrated under the PrimeVigilance brand, in addition to a full range of high quality contract research and trial management services (CRO). Leveraging its CRO expertise, Ergomed also has a drug development portfolio of co-development partnerships and wholly-owned programmes. For further information, visit: http://ergomedplc.com
Related Shares:
ERGO.L